Cardiff Park Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cardiff Park Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,000	Closed	-$100K	–	394
2025 Q3	$100K	Hold	1,000	–	–	0.01%	317
2025 Q2	$82.9K	Buy	+1,000	New	+$79.8K	0.01%	297
2024 Q4	–	Sell	-501	Closed	-$49.5K	–	355
2024 Q3	$49.5K	Sell	501 -2,506	-83%	-$246K	﹤0.01%	297
2024 Q2	$279K	Buy	3,007 +4	+0.1%	+$359	0.03%	203
2024 Q1	$285K	Buy	3,003 +500	+20%	+$46.4K	0.03%	208
2023 Q4	$224K	Hold	2,503	–	–	0.02%	219
2023 Q3	$183K	Hold	2,503	–	–	0.02%	219
2023 Q2	$208K	Hold	2,503	–	–	0.03%	226
2023 Q1	$191K	Hold	2,503	–	–	0.03%	224
2022 Q4	$208K	Hold	2,503	–	–	0.03%	226
2022 Q3	$199K	Hold	2,503	–	–	0.03%	228
2022 Q2	$186K	Hold	2,503	–	–	0.03%	232
2022 Q1	$225K	Hold	2,503	–	–	0.03%	219
2021 Q4	$280K	Buy	+2,503	New	+$302K	0.04%	198

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Cardiff Park Advisors's XBI Position: Q4 2025 in Review

Cardiff Park Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 1,000 shares — an estimated $100K sold.

Cardiff Park Advisors first reported a position in XBI in Q4 2021 and held it in 14 quarters. The position peaked at $285K in Q1 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

Cardiff Park Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
Cardiff Park Advisors sold 1,000 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $100K.
Cardiff Park Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 14 quarters.
Cardiff Park Advisors's State Street SPDR S&P Biotech ETF position peaked at $285K in Q1 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Cardiff Park Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.